Clinical Trial Update: Isoflavone in Prostate-specific Antigen Recurrent Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating isoflavone in biochemical recurrence of prostate cancer conducted by the University of Florida has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biochemical Recurrence of Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Isoflavone (isoflavone)

Snippet

Sponsor: University of Florida | Conditions: Biochemical Recurrent Prostate Cancer | Phase 2 | Status: COMPLETED